Comments
Loading...

DocGo Analyst Ratings

DCGONASDAQ
Logo brought to you by Benzinga Data
$2.73
0.000.00%
Pre-Market: 4:24 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$11.00
Lowest Price Target1
$4.00
Consensus Price Target1
$6.25

DocGo Analyst Ratings and Price Targets | NASDAQ:DCGO | Benzinga

DocGo Inc has a consensus price target of $6.25 based on the ratings of 6 analysts. The high is $11 issued by Deutsche Bank on April 19, 2022. The low is $4 issued by Needham on February 28, 2025. The 3 most-recent analyst ratings were released by Stifel, Needham, and Needham on February 28, 2025, February 28, 2025, and January 16, 2025, respectively. With an average price target of $5.5 between Stifel, Needham, and Needham, there's an implied 101.47% upside for DocGo Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Jan
2
Feb
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Stifel
Needham
Cantor Fitzgerald
BTIG
Canaccord Genuity

1calculated from analyst ratings

Analyst Ratings for DocGo

Buy NowGet Alert
02/28/2025Buy Now101.47%Stifel
David Grossman63%
$6.5 → $5.5MaintainsBuyGet Alert
02/28/2025Buy Now46.52%Needham
Ryan MacDonald60%
$7 → $4MaintainsBuyGet Alert
01/16/2025Buy Now156.41%Needham
Ryan MacDonald60%
$7 → $7ReiteratesBuy → BuyGet Alert
09/20/2024Buy Now83.15%Cantor Fitzgerald
Sarah James51%
$5 → $5ReiteratesOverweight → OverweightGet Alert
08/20/2024Buy Now83.15%Cantor Fitzgerald
Sarah James51%
$5 → $5ReiteratesOverweight → OverweightGet Alert
08/08/2024Buy Now156.41%Needham
Ryan MacDonald60%
$7 → $7ReiteratesBuy → BuyGet Alert
05/09/2024Buy Now156.41%BTIG
David Larsen44%
$11 → $7MaintainsBuyGet Alert
05/09/2024Buy Now83.15%Canaccord Genuity
Richard Close47%
$9 → $5MaintainsBuyGet Alert
05/09/2024Buy Now156.41%Needham
Ryan MacDonald60%
$10 → $7MaintainsBuyGet Alert
05/09/2024Buy Now83.15%Cantor Fitzgerald
Sarah James51%
$11 → $5MaintainsOverweightGet Alert
04/30/2024Buy Now138.1%Stifel
David Grossman63%
$8 → $6.5MaintainsBuyGet Alert
04/11/2024Buy Now229.67%Canaccord Genuity
Richard Close47%
$10 → $9MaintainsBuyGet Alert
04/10/2024Buy Now193.04%Stifel
David Grossman63%
$11 → $8MaintainsBuyGet Alert
04/10/2024Buy Now302.93%BTIG
David Larsen44%
$13 → $11MaintainsBuyGet Alert
02/29/2024Buy Now302.93%Cantor Fitzgerald
Sarah James51%
$13 → $11MaintainsOverweightGet Alert
02/29/2024Buy Now266.3%Canaccord Genuity
Richard Close47%
$11 → $10MaintainsBuyGet Alert
02/29/2024Buy Now266.3%Needham
Ryan MacDonald60%
$14 → $10MaintainsBuyGet Alert
02/23/2024Buy Now302.93%Stifel
David Grossman63%
$12 → $11MaintainsBuyGet Alert
11/27/2023Buy Now339.56%Stifel
David Grossman63%
→ $12ReiteratesBuy → BuyGet Alert
10/02/2023Buy Now376.19%Cantor Fitzgerald
Sarah James51%
→ $13ReiteratesOverweight → OverweightGet Alert
09/19/2023Buy Now376.19%BTIG
David Larsen44%
$15 → $13MaintainsBuyGet Alert
09/18/2023Buy Now339.56%Stifel
David Grossman63%
→ $12ReiteratesBuy → BuyGet Alert
09/18/2023Buy Now412.82%Needham
Ryan MacDonald60%
→ $14ReiteratesBuy → BuyGet Alert
09/14/2023Buy Now376.19%Cantor Fitzgerald
Sarah James51%
→ $13ReiteratesOverweight → OverweightGet Alert
09/07/2023Buy Now412.82%Needham
Ryan MacDonald60%
→ $14ReiteratesBuy → BuyGet Alert
08/23/2023Buy Now412.82%Needham
Ryan MacDonald60%
→ $14ReiteratesBuy → BuyGet Alert
08/22/2023Buy Now412.82%Needham
Ryan MacDonald60%
→ $14ReiteratesBuy → BuyGet Alert
08/18/2023Buy Now449.45%BTIG
David Larsen44%
→ $15Initiates → BuyGet Alert
08/08/2023Buy Now412.82%Needham
Ryan MacDonald60%
→ $14ReiteratesBuy → BuyGet Alert
07/31/2023Buy Now339.56%Stifel
David Grossman63%
$12 → $12ReiteratesBuy → BuyGet Alert
06/21/2023Buy Now339.56%Stifel
David Grossman63%
→ $12ReiteratesBuy → BuyGet Alert
06/21/2023Buy Now376.19%Canaccord Genuity
Richard Close47%
→ $13ReiteratesBuy → BuyGet Alert
06/21/2023Buy Now412.82%Needham
Ryan MacDonald60%
→ $14ReiteratesBuy → BuyGet Alert
04/21/2023Buy Now412.82%Needham
Ryan MacDonald60%
→ $14Reiterates → BuyGet Alert
04/21/2023Buy Now302.93%Cantor Fitzgerald
Sarah James51%
→ $11Initiates → OverweightGet Alert
03/14/2023Buy Now412.82%Needham
Ryan MacDonald60%
→ $14Reiterates → BuyGet Alert
04/19/2022Buy Now302.93%Deutsche Bank
Pito Chickering67%
→ $11Initiates → BuyGet Alert

FAQ

Q

What is the target price for DocGo (DCGO) stock?

A

The latest price target for DocGo (NASDAQ:DCGO) was reported by Stifel on February 28, 2025. The analyst firm set a price target for $5.50 expecting DCGO to rise to within 12 months (a possible 101.47% upside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for DocGo (DCGO)?

A

The latest analyst rating for DocGo (NASDAQ:DCGO) was provided by Stifel, and DocGo maintained their buy rating.

Q

When was the last upgrade for DocGo (DCGO)?

A

There is no last upgrade for DocGo

Q

When was the last downgrade for DocGo (DCGO)?

A

There is no last downgrade for DocGo.

Q

When is the next analyst rating going to be posted or updated for DocGo (DCGO)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DocGo, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DocGo was filed on February 28, 2025 so you should expect the next rating to be made available sometime around February 28, 2026.

Q

Is the Analyst Rating DocGo (DCGO) correct?

A

While ratings are subjective and will change, the latest DocGo (DCGO) rating was a maintained with a price target of $6.50 to $5.50. The current price DocGo (DCGO) is trading at is $2.73, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch